FDA sends warning letters to companies claiming to treat Alzheimer’s

The Food as well as Drug Administration said Monday the item sent warning letters to more than a dozen companies the agency said are “illegally selling” products in which claim to prevent or cure Alzheimer’s disease.

Many of these products, which are often sold on websites as well as social media platforms, “have not been reviewed by the FDA as well as are not proven safe as well as effective to treat the diseases as well as health conditions they claim to treat,” the FDA said in a press Discharge.

“These products may be ineffective, unsafe as well as could prevent a person via seeking an appropriate diagnosis as well as treatment,” the agency added.

As many as 5.5 million Americans over the age of 65 suffer via Alzheimer’s, a progressive disease in which often affects memory, thinking as well as behavior. The number of Americans with the disease is actually likely to grow, according to the Department of Health & Human Services.

The FDA is actually responsible for taking action against any misbranded dietary supplement product after the item reaches the market.

More than 50 percent of U.S. adults use dietary supplements, the FDA says. Between 2007 as well as 2016 nearly 800 over-the-counter dietary supplements were found to contain unapproved drug ingredients, according to a study published in October.

The FDA said the products, which FDA Commissioner Scott Gottlieb labeled a “scam,” have come inside the form of tablets, capsules as well as oils. The 17 companies who were sent letters have been asked to respond within 15 days.